Low admission LDL-cholesterol is associated with increased 3-year all-cause mortality in patients with non ST segment elevation myocardial infarction
- PMID: 19437396
Low admission LDL-cholesterol is associated with increased 3-year all-cause mortality in patients with non ST segment elevation myocardial infarction
Abstract
Background: The relationship between admission low-density lipoprotein (LDL) levels and long-term outcomes has not been established in patients with acute coronary syndrome. We tested the hypothesis that patients who develop non-ST segment elevation myocardial infarction (NSTEMI) despite low LDL have a worse cardiovascular outcome in the long term.
Methods: Patients admitted with NSTEMI between 1 January 1997 and 31 December 2000 and with fasting lipid profiles measured within 24 hours of admission were selected for analysis. Baseline characteristics and 3-year all-cause mortality were compared between the patients with LDL above and below the median. Multivariate analysis was used to determine the predictors of all-cause mortality, and adjusted survival was analyzed using the Cox proportional hazard model.
Results: Of the total of 517 patients, 264 had LDL <or= 105 mg/dL and 253 had LDL > 105 mg/dL. There was no difference in age, gender, severity of coronary artery disease, and left ventricular ejection fraction between the 2 groups. Thirty-six percent of patients with LDL <or= 105 mg/dL and 24% of patients with LDL > 105 mg/dL were on lipid-lowering therapy on admission. After 3 years, patients with admission LDL <or= 105 mg/dL had higher all-cause mortality rate compared to patients with LDL > 105 mg/dL (14.8% vs. 7.1%, p = 0.005). The higher all-cause mortality persisted (OR 1.8, 95% CI 1.0-3.5, p = 0.05) even after adjustment for confounding variables.
Conclusions: In our cohort, lower LDL-cholesterol at admission was associated with decreased 3-year survival in patients with NSTEMI. Whether this was a result of current therapy or a marker for worse baseline characteristics needs to be studied further.
Comment in
-
Post-infarction risk is higher with low LDL? Pondering global risk, treatment bias and the nature of outcome events.Cardiol J. 2009;16(3):195-6. Cardiol J. 2009. PMID: 19437392 No abstract available.
Similar articles
-
Low admission triglyceride and mortality in acute coronary syndrome patients.Cardiol J. 2011;18(3):297-303. Cardiol J. 2011. PMID: 21660920
-
Association of elevated fasting glucose with increased short-term and 6-month mortality in ST-segment elevation and non-ST-segment elevation acute coronary syndromes: the Global Registry of Acute Coronary Events.Arch Intern Med. 2009 Feb 23;169(4):402-9. doi: 10.1001/archinternmed.2008.572. Arch Intern Med. 2009. PMID: 19237725
-
Soluble CXCL16 predicts long-term mortality in acute coronary syndromes.Circulation. 2009 Jun 30;119(25):3181-8. doi: 10.1161/CIRCULATIONAHA.108.806877. Epub 2009 Jun 15. Circulation. 2009. PMID: 19528340
-
Mean platelet volume/platelet count ratio as a predictor of long-term mortality after non-ST-elevation myocardial infarction.Platelets. 2011;22(8):557-66. doi: 10.3109/09537104.2011.584086. Epub 2011 Jun 30. Platelets. 2011. PMID: 21714700 Review.
-
LDL-cholesterol differences predicted survival benefit in statin trials by the surrogate threshold effect (STE).J Clin Epidemiol. 2009 Mar;62(3):328-36. doi: 10.1016/j.jclinepi.2008.06.004. Epub 2008 Oct 1. J Clin Epidemiol. 2009. PMID: 18834708 Review.
Cited by
-
Outcomes of Patients with Normal LDL-Cholesterol at Admission for Acute Coronary Syndromes: Lower Is Not Always Better.J Cardiovasc Dev Dis. 2024 Apr 15;11(4):120. doi: 10.3390/jcdd11040120. J Cardiovasc Dev Dis. 2024. PMID: 38667738 Free PMC article.
-
Variation in VEGFA and risk of cardiovascular disease in the UK Biobank.Front Cardiovasc Med. 2023 Nov 28;10:1240288. doi: 10.3389/fcvm.2023.1240288. eCollection 2023. Front Cardiovasc Med. 2023. PMID: 38089766 Free PMC article.
-
Impact of Low-Density Lipoprotein Cholesterol Levels at Acute Coronary Syndrome Admission on Long-Term Clinical Outcomes.J Atheroscler Thromb. 2024 Apr 1;31(4):444-460. doi: 10.5551/jat.64368. Epub 2023 Oct 12. J Atheroscler Thromb. 2024. PMID: 37821363 Free PMC article.
-
Time-varying effect of postoperative cholesterol profile on long-term outcomes of isolated coronary artery bypass graft surgery.Lipids Health Dis. 2023 Oct 3;22(1):163. doi: 10.1186/s12944-023-01927-8. Lipids Health Dis. 2023. PMID: 37789387 Free PMC article.
-
A realistic approach to evaluating the effect of baseline lipid profile in postcoronary artery bypass grafting surgery.Clin Cardiol. 2023 Nov;46(11):1408-1417. doi: 10.1002/clc.24132. Epub 2023 Aug 18. Clin Cardiol. 2023. PMID: 37594287 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical